| 000 | 01508 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515112940.0 | ||
| 264 | 0 | _c20081103 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1440-1681 | ||
| 024 | 7 |
_a10.1111/j.1440-1681.2008.04915.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Bi-Lian | |
| 245 | 0 | 0 |
_aInhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms. _h[electronic resource] |
| 260 |
_bClinical and experimental pharmacology & physiology _cAug 2008 |
||
| 300 |
_a904-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C19 |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 700 | 1 | _aZhang, Wei | |
| 700 | 1 | _aLi, Qing | |
| 700 | 1 | _aLi, Ya-Lin | |
| 700 | 1 | _aHe, Yi-Jing | |
| 700 | 1 | _aFan, Lan | |
| 700 | 1 | _aWang, Lian-Sheng | |
| 700 | 1 | _aLiu, Zhao-Qian | |
| 700 | 1 | _aZhou, Hong-Hao | |
| 773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 35 _gno. 8 _gp. 904-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.2008.04915.x _zAvailable from publisher's website |
| 999 |
_c17847535 _d17847535 |
||